Stimulated polymorphonuclear neutrophils (PMN) metabolize their arachidonate and phospholipid stores into a series of bioactive products: leukotriene (LT)B4, 5-hydroxyicosatetraenoate (5-HETE), prostaglandins (PG), platelet-activating factor (PAF), and diacylglycerol (DAG). We postulate that these products interact to influence functional responses of various tissues as follows. LTB4, PAF, and 5-HETE excite cells by binding to their respective plasma membrane receptors. Receptors for LTB4 and PAF operate by raising cytosolic Ca and activating protein kinase C (PKC) through a linkage cascade involving GTP-binding proteins, phospholipase C, and cleavage of phosphatidylinositol diphosphate into inositol triphosphate and DAG. Inositol triphosphate releases Ca2+ from subcellular pools to cytosol whereas DAG directly activates PKC by a Ca2+-enhanced reaction. Receptors for 5-HETE operate by a different mechanism, (which, we postulate, is synergistic with that used by PAF and LTB4), to raise cytosolic Ca2+ and promote PKC activation. The elevated Ca2+ and activated PKC then initiate function. However, PG and, under certain conditions, activated PKC inhibit function; they may act by down-regulating receptors for LTB4, PAF, and 5-HETE or by interfering with these receptors' linkages to GTP-binding proteins. Our concepts will be tested on human PMN, PMIN cytoplasts, and PMIN isolated organelles in studies that: a) define the subcellular distributions and binding parameters of receptors for LTB4, PAF, 5-HETE, and PG; b) examine these receptors' specific linkages to, and effects upon, Ca2+ fluxes and PKC activation: c) determine the influences of PG and activated PKC on these receptors' binding of ligands and functional linkages to GTP-binding proteins; and d) evaluate the roles of LTB4. 5-HETE, PG, PAF, DAG, Ca2+ and PKC in PMN responses to exogenous stimuli (e.g., chemotactic peptides and calcium ionophores) using pharmacologic agents and other methods that selective abrogate PMN synthesis of or responses to the lipid products. Our studies rely heavily upon the use of PMN under physiological conditions and the reconstruction of relevant cell- free models comprised of purified PMN organelles, PKC, and GTP- binding proteins. Ultimately, we aim to define how the lipid products stimulate diverse cell types and to implicate the products in stimulus-response coupling events. Since these products and their cells of origin appear involved in inflammatory, allergic, anaphylactic, and bronchospastic reactions, this proposal is relevant to the general fields of cellular biology, host defense mechanisms, pulmonary physiology, pharmacology, and clinical medicine.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL026257-10
Application #
3338536
Study Section
Pathology A Study Section (PTHA)
Project Start
1980-12-01
Project End
1993-11-30
Budget Start
1989-12-01
Budget End
1990-11-30
Support Year
10
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Type
Schools of Medicine
DUNS #
041418799
City
Winston-Salem
State
NC
Country
United States
Zip Code
27106
Kuroki, M; O'Flaherty, J T (1997) Differential effects of a mitogen-activated protein kinase kinase inhibitor on human neutrophil responses to chemotactic factors. Biochem Biophys Res Commun 232:474-7
O'Flaherty, J T; Kuroki, M; Nixon, A B et al. (1996) 5-Oxo-eicosanoids and hematopoietic cytokines cooperate in stimulating neutrophil function and the mitogen-activated protein kinase pathway. J Biol Chem 271:17821-8
O'Flaherty, J T; Kuroki, M; Nixon, A B et al. (1996) 5-Oxo-eicosatetraenoate is a broadly active, eosinophil-selective stimulus for human granulocytes. J Immunol 157:336-42
Sozzani, S; Zhou, D; Locati, M et al. (1996) Stimulating properties of 5-oxo-eicosanoids for human monocytes: synergism with monocyte chemotactic protein-1 and -3. J Immunol 157:4664-71
Wijkander, J; O'Flaherty, J T; Nixon, A B et al. (1995) 5-Lipoxygenase products modulate the activity of the 85-kDa phospholipase A2 in human neutrophils. J Biol Chem 270:26543-9
O'Flaherty, J T; Tessner, T; Greene, D et al. (1994) Comparison of 1-O-alkyl-, 1-O-alk-1'-enyl-, and 1-O-acyl-2-acetyl-sn-glycero-3-phosphoethanolamines and -3-phosphocholines as agonists of the platelet-activating factor family. Biochim Biophys Acta 1210:209-16
O'Flaherty, J T; Rossi, A G (1993) 5-hydroxyicosatetraenoate stimulates neutrophils by a stereospecific, G protein-linked mechanism. J Biol Chem 268:14708-14
O'Flaherty, J T; Cordes, J; Redman, J et al. (1993) 5-Oxo-eicosatetraenoate, a potent human neutrophil stimulus. Biochem Biophys Res Commun 192:129-34
O'Flaherty, J T; Jacobson, D P; Redman, J F (1992) Regulation of platelet-activating-factor receptors and the desensitization response in polymorphonuclear neutrophils. Biochem J 288 ( Pt 1):241-8
O'Flaherty, J T; Rossi, A G; Redman, J F et al. (1991) Tumor necrosis factor-alpha regulates expression of receptors for formyl-methionyl-leucyl-phenylalanine, leukotriene B4, and platelet-activating factor. Dissociation from priming in human polymorphonuclear neutrophils. J Immunol 147:3842-7

Showing the most recent 10 out of 38 publications